NASDAQ: GTBPGt Biopharma Inc Stock Ownership - Who owns Gt Biopharma?
Insider buying vs selling
Have Gt Biopharma Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when GTBP insiders and whales buy or sell their stock.
GTBP Shareholders
What type of owners hold Gt Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Michael Martin Breen | 2.37% | 856,218 | $279.13k | Insider |
| Vanguard Capital Management LLC | 1.25% | 451,875 | $147.31k | Institution |
| Manu Ohri | 0.97% | 350,000 | $114.10k | Insider |
| Geode Capital Management LLC | 0.82% | 294,459 | $95.99k | Institution |
| Vanguard Fiduciary Trust Co | 0.63% | 225,938 | $73.66k | Institution |
| Arax Advisory Partners | 0.26% | 93,627 | $30.52k | Institution |
| Citadel Advisors LLC | 0.18% | 66,165 | $21.57k | Institution |
| Seacrest Wealth Management LLC | 0.14% | 50,000 | $16.30k | Institution |
| Ubs Group Ag | 0.13% | 45,970 | $14.99k | Institution |
| Two Sigma Securities LLC | 0.09% | 31,796 | $10.37k | Institution |
GTBP vs Biotech Stocks
Gt Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.